Sun Pharmaceutical Industries Ltd.’s quarterly profit fell by more than half as sales and other income declined, and its U.S. arm reported an operating loss. Consolidated net profit of the nation’s largest drugmaker fell 52% sequentially to Rs 894.15 crore in the quarter ended March, according to an exchange filing.
Indian shares closed higher on Thursday, helped by gains in financials and information technology stocks, while a steady decline in daily COVID-19 cases also helped investor sentiment.
Sun Pharmaceutical Industries Ltd Board approves final dividend of Rs 2 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Indian shares flat as financials counter gains in IT stocks reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.